This company listing is no longer active
Audientes Past Earnings Performance
Past criteria checks 0/6
Key information
-82.9%
Earnings growth rate
-82.9%
EPS growth rate
| Medical Equipment Industry Growth | -1.7% |
| Revenue growth rate | n/a |
| Return on equity | -66.3% |
| Net Margin | -3,161.8% |
| Next Earnings Update | 17 Nov 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Audientes makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 22 | 0 | -14 | 6 | 0 |
| 31 Dec 21 | 0 | -13 | 6 | 0 |
| 30 Sep 21 | 0 | -10 | 5 | 0 |
| 30 Jun 21 | 0 | -10 | 4 | 0 |
| 31 Mar 21 | 0 | -8 | 3 | 0 |
Quality Earnings: AUDNTS is currently unprofitable.
Growing Profit Margin: AUDNTS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if AUDNTS's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare AUDNTS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AUDNTS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (4.8%).
Return on Equity
High ROE: AUDNTS has a negative Return on Equity (-66.25%), as it is currently unprofitable.